Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Agius

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Neurologic Clinics|May 1, 1994
Acquired myasthenia gravis. ImmunopathologyD P Richman, M A Agius
Seminars in Neurology|June 1, 1994
Myasthenia gravis: pathogenesis and treatmentD P Richman, M A Agius
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1986
Suppression of development of experimental autoimmune myasthenia gravis with isogeneic monoclonal anti-idiotopic antibodyM A Agius, D P Richman
Archives of Neurology|July 1, 1997
Role of antiribosomal P protein antibodies in the diagnosis of lupus isolated to the central nervous systemM A Agius, J W Chan, S Chung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1987
Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membraneA L Corey, D P Richman, M A Agius, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1988
Monoclonal anti-idiotopic antibodies against myasthenia-inducing anti-acetylcholine receptor monoclonal antibodies. Preponderance of nonparatope-directed antibodies affecting antigen bindingM A Agius, C J Geannopoulos, R H Fairclough, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 17, 1998
Morvan's fibrillary chorea: a paraneoplastic manifestation of thymomaE K Lee, R A Maselli, W G Ellis, et al.
Acta Neurologica Scandinavica|September 9, 1999
High prevalence of anti-alpha-crystallin antibodies in multiple sclerosis: correlation with severity and activity of diseaseM A Agius, C A Kirvan, A L Schafer, et al.
Annals of the New York Academy of Sciences|January 1, 1987
Human x human hybridomas from patients with myasthenia gravis: possible tools for idiotypic therapy for myastheniaD A Blair, M Mihovilovic, M A Agius, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2004
An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with multiple sclerosisT L Vollmer, J T Phillips, A D Goodman, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Neurologic Clinics|May 1, 1994
Acquired myasthenia gravis. ImmunopathologyD P Richman, M A Agius
Seminars in Neurology|June 1, 1994
Myasthenia gravis: pathogenesis and treatmentD P Richman, M A Agius
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1986
Suppression of development of experimental autoimmune myasthenia gravis with isogeneic monoclonal anti-idiotopic antibodyM A Agius, D P Richman
Archives of Neurology|July 1, 1997
Role of antiribosomal P protein antibodies in the diagnosis of lupus isolated to the central nervous systemM A Agius, J W Chan, S Chung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1987
Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membraneA L Corey, D P Richman, M A Agius, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1988
Monoclonal anti-idiotopic antibodies against myasthenia-inducing anti-acetylcholine receptor monoclonal antibodies. Preponderance of nonparatope-directed antibodies affecting antigen bindingM A Agius, C J Geannopoulos, R H Fairclough, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 17, 1998
Morvan's fibrillary chorea: a paraneoplastic manifestation of thymomaE K Lee, R A Maselli, W G Ellis, et al.
Acta Neurologica Scandinavica|September 9, 1999
High prevalence of anti-alpha-crystallin antibodies in multiple sclerosis: correlation with severity and activity of diseaseM A Agius, C A Kirvan, A L Schafer, et al.
Annals of the New York Academy of Sciences|January 1, 1987
Human x human hybridomas from patients with myasthenia gravis: possible tools for idiotypic therapy for myastheniaD A Blair, M Mihovilovic, M A Agius, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2004
An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with multiple sclerosisT L Vollmer, J T Phillips, A D Goodman, et al.
Pageof 2